FDA Approves Qternmet XR, New Type 2 Diabetes Combo Pill

The U.S. Food and Drug Administration (FDA) has approved Qternmet XR extended-release tablets as an adjunct treatment to diet[1] and exercise[2] in adults with type 2 diabetes[3]. According to a press release from manufacturer AstraZeneca[4], the oral medicine is a combination of the SGLT2 inhibitor[5] dapagliflozin, the DPP-4 inhibitor[6] saxagliptin and metformin extended-release.

The approval was based on the results of two phase 3 trials[7] evaluating different combinations of dapagliflozin and saxagliptin on a base of metformin over 24 weeks.

Advertisement

Want to learn more about SGLT2 inhibitors, DPP-4 inhibitors and metformin? Read “Diabetes Medicine: SGLT2 Inhibitors,”[8] “Diabetes Medicine: DPP-4 Inhibitors”[9] and “What to Know About Metformin.”[10]

Endnotes:
  1. diet: https://www.diabetesselfmanagement.com/nutrition-exercise/meal-planning/
  2. exercise: https://www.diabetesselfmanagement.com/nutrition-exercise/exercise/
  3. type 2 diabetes: https://www.diabetesselfmanagement.com/diabetes-resources/definitions/type-2-diabetes/
  4. press release from manufacturer AstraZeneca: https://www.astrazeneca.com/media-centre/press-releases/2019/qternmet-xr-approved-in-the-us-for-the-treatment-of-type-2-diabetes-03052019.html
  5. SGLT2 inhibitor: https://www.diabetesselfmanagement.com/blog/diabetes-medicine-sglt2-inhibitors/
  6. DPP-4 inhibitor: https://www.diabetesselfmanagement.com/blog/diabetes-medicine-dpp-4-inhibitors/
  7. phase 3 trials: https://www.fda.gov/patients/drug-development-process/step-3-clinical-research
  8. “Diabetes Medicine: SGLT2 Inhibitors,”: https://www.diabetesselfmanagement.com/blog/diabetes-medicine-sglt2-inhibitors/
  9. “Diabetes Medicine: DPP-4 Inhibitors”: https://www.diabetesselfmanagement.com/blog/diabetes-medicine-dpp-4-inhibitors/
  10. “What to Know About Metformin.”: https://www.diabetesselfmanagement.com/blog/what-to-know-about-metformin/

Source URL: https://www.diabetesselfmanagement.com/blog/fda-approves-qternmet-xr-new-type-2-diabetes-combo-pill/


Diane Fennell: Diane Fennell has been an editor at Diabetes Self-Management magazine since 2003. She is currently the Editorial Director. (Diane Fennell is not a medical professional.)

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.